Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Answer

Staff  |  Issue: January 2009  |  January 1, 2009

Take the Challenge.

99214-25, 96413, J1745 x 20, 90775, J1200, 90761-59, J7040, Diagnosis 714.0 The visit would be considered as 99214.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although the history was only problem focused, the exam was detailed, and the medical decision making was of moderate complexity—making this a level-four visit. You only need two out of three components for an established visit. A modifier -25 is needed on the office visit because it was separate and significant to the infusion.

The infusion of infliximab would be coded as 96413, one unit. Because of the adverse reaction, the infusion was halted, and saline was used to flush out the infliximab. In this circumstance, the code 90761 with a modifier -59 can be billed. The “subsequent” code has to be used because only one initial code is allowed—here it is the 96413 code—when billing in the drug administration category. The modifier -59 should be billed to alert the carrier that the saline was used to flush out the drug and was not just used to move the drug along. The 90775 was used to bill for the push of diphenhydramine for the adverse reaction of the infliximab.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Again, the “subsequent” code is used because of the initial coding rule.

Share: 

Filed under:Billing/CodingPractice Support Tagged with:BillingCodinginfliximabRheumatoid arthritis

Related Articles

    New HCPCS Modifiers Replace -59 on January 1, 2015

    December 1, 2014

    Referred to as -X modifiers, they are designed to define specific subsets of -59 modifier

    Coding Corner Answer

    August 1, 2007

    August’s coding answer

    Coding Corner Answer

    December 1, 2007

    Decembers’s Coding Challenge Answer

    Coding Corner Answer: A Quiz on Modifiers

    February 18, 2019

    Take the challenge. 1. A—Modifier -25 is defined as a significant, separately identifiable evaluation and management (E/M) service by the same physician or other qualified healthcare professional on the same day of the procedure or other service. It is to be placed on the E/M visit only because it attests to the payer there is…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences